View in EDS HTML Full Text PDF Full Text

Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.

Saved in:
Bibliographic Details
Title: Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.
Authors: Kelkar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; and Harvard T.H. Chan School of Public Health, Boston, Massachusetts (A.H.K.)., Cliff ERS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; Harvard T.H. Chan School of Public Health, Boston; and Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts (E.R.S.C.)., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.)., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.)., Dijk SW; Department of Radiology and Nuclear Medicine and Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands (S.W.D.)., Krijkamp EM; Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, and Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands (E.M.K.)., Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts (R.R.)., Zurko JC; Division of Hematology & Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (J.C.Z.)., Hamadani M; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin (M.H.)., Hunink MGM; Harvard T.H. Chan School of Public Health, Boston, and Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts; and Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands (M.G.M.H.)., Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.).
Source: Annals of internal medicine [Ann Intern Med] 2023 Dec; Vol. 176 (12), pp. 1625-1637. Date of Electronic Publication: 2023 Dec 05.
Publication Type: Journal Article
Journal Info: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38048587
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kelkar+AH%22">Kelkar AH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; and Harvard T.H. Chan School of Public Health, Boston, Massachusetts (A.H.K.).<br /><searchLink fieldCode="AU" term="%22Cliff+ERS%22">Cliff ERS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; Harvard T.H. Chan School of Public Health, Boston; and Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts (E.R.S.C.).<br /><searchLink fieldCode="AU" term="%22Jacobson+CA%22">Jacobson CA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.).<br /><searchLink fieldCode="AU" term="%22Abel+GA%22">Abel GA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.).<br /><searchLink fieldCode="AU" term="%22Dijk+SW%22">Dijk SW</searchLink>; Department of Radiology and Nuclear Medicine and Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands (S.W.D.).<br /><searchLink fieldCode="AU" term="%22Krijkamp+EM%22">Krijkamp EM</searchLink>; Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, and Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands (E.M.K.).<br /><searchLink fieldCode="AU" term="%22Redd+R%22">Redd R</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts (R.R.).<br /><searchLink fieldCode="AU" term="%22Zurko+JC%22">Zurko JC</searchLink>; Division of Hematology & Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (J.C.Z.).<br /><searchLink fieldCode="AU" term="%22Hamadani+M%22">Hamadani M</searchLink>; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin (M.H.).<br /><searchLink fieldCode="AU" term="%22Hunink+MGM%22">Hunink MGM</searchLink>; Harvard T.H. Chan School of Public Health, Boston, and Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts; and Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands (M.G.M.H.).<br /><searchLink fieldCode="AU" term="%22Cutler+C%22">Cutler C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, and Harvard Medical School, Boston, Massachusetts (C.A.J., G.A.A., C.C.).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372351%22">Annals of internal medicine</searchLink> [Ann Intern Med] 2023 Dec; Vol. 176 (12), pp. 1625-1637. <i>Date of Electronic Publication: </i>2023 Dec 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+College+of+Physicians--American+Society+of+Internal+Medicine%22">American College of Physicians--American Society of Internal Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372351 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1539-3704 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034819%22">00034819 </searchLink><i>NLM ISO Abbreviation: </i>Ann Intern Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38048587
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7326/M22-2276
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1625
    Titles:
      – TitleFull: Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kelkar AH
      – PersonEntity:
          Name:
            NameFull: Cliff ERS
      – PersonEntity:
          Name:
            NameFull: Jacobson CA
      – PersonEntity:
          Name:
            NameFull: Abel GA
      – PersonEntity:
          Name:
            NameFull: Dijk SW
      – PersonEntity:
          Name:
            NameFull: Krijkamp EM
      – PersonEntity:
          Name:
            NameFull: Redd R
      – PersonEntity:
          Name:
            NameFull: Zurko JC
      – PersonEntity:
          Name:
            NameFull: Hamadani M
      – PersonEntity:
          Name:
            NameFull: Hunink MGM
      – PersonEntity:
          Name:
            NameFull: Cutler C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1539-3704
          Numbering:
            – Type: volume
              Value: 176
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Annals of internal medicine
              Type: main
ResultId 1